Your browser doesn't support javascript.
loading
Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan.
Takahashi, Naoto; Nishiwaki, Kaichi; Nakaseko, Chiaki; Aotsuka, Nobuyuki; Sano, Koji; Ohwada, Chikako; Kuroki, Jun; Kimura, Hideo; Tokuhira, Michihide; Mitani, Kinuko; Fujikawa, Kazuhisa; Iwase, Osamu; Ohishi, Kohshi; Kimura, Fumihiko; Fukuda, Tetsuya; Tanosaki, Sakae; Takahashi, Saori; Kameoka, Yoshihiro; Nishikawa, Hiroyoshi; Wakita, Hisashi.
Affiliation
  • Takahashi N; Department of Hematology, Nephrology and Rheumatology, Akita University Graduate School of Medicine naotot@doc.med.akita-u.ac.jp.
  • Nishiwaki K; Department of Oncology and Hematology, Jikei University Kashiwa Hospital.
  • Nakaseko C; Department of Hematology, International University of Health and Welfare School of Medicine, Narita.
  • Aotsuka N; Department of Hematology, Chiba University Hospital.
  • Sano K; Department of Hematology and Oncology, Japanese Red Cross Narita Hospital.
  • Ohwada C; Department of Oncology and Hematology, Jikei University Kashiwa Hospital.
  • Kuroki J; Department of Hematology, Chiba University Hospital.
  • Kimura H; Department of Internal Medicine, Yuri General Hospital, Yurihonjo.
  • Tokuhira M; Department of Hematology, Northern Fukushima Medical Center, Date.
  • Mitani K; Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe.
  • Fujikawa K; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi.
  • Iwase O; Department of Hematology, Chibaken Saiseikai Narashino Hospital.
  • Ohishi K; Department of Hematology, Tokyo Medical University Hachioji Medical Center.
  • Kimura F; Transfusion Medicine and Cell Therapy, Mie University Hospital, Tsu.
  • Fukuda T; Division of Hematology, National Defense Medical College, Tokorozawa.
  • Tanosaki S; Department of Hematology, Tokyo Medical and Dental University Hospital.
  • Takahashi S; Department of Hematology, Tottori University Hospital, Yonago.
  • Kameoka Y; Department of Hematology, The Fraternity Memorial Hospital, Tokyo.
  • Nishikawa H; Clinical Research Promotion and Support Center, Akita University Hospital.
  • Wakita H; Clinical Research Promotion and Support Center, Akita University Hospital.
Haematologica ; 103(11): 1835-1842, 2018 11.
Article in En | MEDLINE | ID: mdl-29976734
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrimidines / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Consolidation Chemotherapy Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Haematologica Year: 2018 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyrimidines / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Consolidation Chemotherapy Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Haematologica Year: 2018 Type: Article